⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2888790 | 0.74 | — | — | |
| SCHEMBL5280090 | 0.73 | — | — | |
| Potassium SCHEMBL6131356 | 0.73 | — | — | |
| SCHEMBL5277277 | 0.73 | — | — | |
| SCHEMBL10460038 | 0.73 | — | — | |
| SCHEMBL1244023 | 0.73 | — | — | |
| Ammonia Solution, Strong SCHEMBL11283492 | 0.73 | — | — | |
| SCHEMBL5276709 | 0.73 | — | — | |
| Nitric Acid SCHEMBL29191086 | 0.70 | CA5A (0.33) | — | |
| SCHEMBL5279318 | 0.68 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1859781-A2 | Brightening and/or colouring agent with triazoles | Henkel Kommanditgesellschaft auf Aktien (DE) | 2007-11-28 | — | — | EP | disclosed |
| EP-0048555-B1 | AMINO-1,2,4-TRIAZOLE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | GLAXO GROUP LIMITED (GB) | 1985-12-04 | — | — | EP | disclosed |
| US-4481199-A | HISTAMINE H2-ANTAGONISTS | GLAXO GROUP LIMITED (GB) | 1984-11-06 | — | — | US | disclosed |
| EP-0048555-A1 | Amino-1,2,4-triazole derivatives, processes for their preparation and pharmaceutical compositions containing them | GLAXO GROUP LIMITED (GB) | 1982-03-31 | — | — | EP | disclosed |
| EP-0040408-A1 | Beta-lactam compounds and process for production thereof | SANRAKU-OCEAN CO., LTD. (JP) | 1981-11-25 | — | — | EP | disclosed |